Question

A patient with chronic kidney disease stage 4 (eGFR <30 mL/min/1.73 m²) has persistent hyperkalaemia. Which class of drug can help manage hyperkalaemia in such patients while continuing an ACE inhibitor?

Accepted Answer

Potassium binders (e.g., sodium zirconium cyclosilicate)

Answer

Phosphate binders

Answer

Beta-2 agonists

Answer

Carbonic anhydrase inhibitors

Answer

Calcium channel blockers

Practice question

A patient with chronic kidney disease stage 4 (eGFR <30 mL/min/1.73 m²) has persistent hyperkalaemia. Which class of drug can help manage hyperkalaemia in such patients while continuing an ACE inhibitor?